monthly cover
Senior Spectrum Newspaper
August 2017
Current Golden Pages Cover
Golden Pages
Current Generation Boomer cover
Generation Boomer

Senior Spectrum Publications

Vision - Ophthalmology
by Dr. Michael Fischer, M.D.
Nevada Eye Surgery Center
top of page

Playing the Angle 

Michael Fischer, M.D.
Michael Fischer, M.D.

The FDA recently approved a new drug for the treatment of “open-angle glaucoma,” which is the most common form of the eye disease. Sometimes referred to as “chronic glaucoma,” openangle glaucoma is particularly dangerous because it can progress gradually and go unnoticed. Affecting 70 percent to 80 percent of those suffering from the disease, openangle glaucoma typically occurs among individuals over the age of 50, and its risk of occurrence increases with age. It is characterized by a clogged drainage system in the eye, which results in a buildup in aqueous fluid and rise in intraocular pressure. The new drug for treatment of this form of the disease, tafluprost, works by reducing inner eye pressure. It should be noted, open-angle glaucoma is known as the “silent thief of sight” because it may not present noticeable symptoms; an eye exam is necessary for diagnosis.


If you experience any difficulties with your vision, see your doctor or call us at 775 - 882-2988. We are conveniently located at 3839 N. Carson Street. Hours are 8-5 p.m., Monday-Friday, by appointment. M/C, Visa, & Medicare.